Net gamma exposure for CRISPR Therapeutics AG (CRSP) options was positive at the Nov 4, 2026 close, about $848.61K per 1% move in the stock. It has been positive on 14 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for CRSP, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for CRSP, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for CRSP, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
CRSP Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is CRSP gamma exposure positive or negative?
CRISPR Therapeutics AG net gamma exposure was positive on Nov 4, 2026, at $848.61K. It has been positive on 14 of the last 20 trading days.
How has CRSP gamma exposure changed recently?
CRISPR Therapeutics AG net gamma exposure went from $209.73K on Oct 7, 2026 to $848.61K on Nov 4, 2026. See the CRSP gamma exposure history for a longer view.
What is CRISPR Therapeutics AG?
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics.